Stock Quality:
BIOL RSI Chart
Growth
Profitability
Size
Dilution Risk
Balance Sheet
Momentum
Funds Popularity
Insider Trading
Historical Charts for Stock Metrics
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2024 | 48.8M | 46.1M | 46.0M | 0 |
| 2023 | 48.8M | 50.8M | 49.7M | 49.2M |
| 2022 | 41.2M | 44.3M | 46.8M | 48.5M |
| 2021 | 26.1M | 32.3M | 35.3M | 39.2M |
| 2020 | 32.3M | 26.5M | 24.4M | 22.8M |
| 2019 | 46.5M | 43.0M | 40.7M | 37.8M |
| 2018 | 46.1M | 45.6M | 45.7M | 46.2M |
| 2017 | 51.7M | 50.5M | 48.1M | 46.9M |
| 2016 | 48.6M | 50.6M | 52.6M | 51.8M |
| 2015 | 47.0M | 48.7M | 47.2M | 48.5M |
| 2014 | 53.4M | 49.3M | 49.7M | 47.7M |
| 2013 | 59.6M | 61.7M | 60.3M | 56.4M |
| 2012 | 50.6M | 51.1M | 51.8M | 57.4M |
| 2011 | 30.7M | 36.5M | 43.4M | 48.9M |
| 2010 | 0 | 37.1M | 30.8M | 24.6M |
| 2009 | 0 | 0 | 0 | 43.3M |
| CEO | Mr. John R. Beaver |
|---|---|
| WEBSITE | biolase.com |
| SECTOR | Healthcare |
| INDUSTRY | Medical Devices |
| EMPLOYEES | 188 |